Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

被引：0
|
作者：
R. Langham
D. Kelly
A. Cox
N. Thomson
H. Holthöfer
P. Zaoui
N. Pinel
D. Cordonnier
R. Gilbert
机构：
[1] University of Melbourne Department of Medicine,
[2] St. Vincent's Hospital,undefined
[3] 41 Victoria Parade,undefined
[4] Fitzroy,undefined
[5] Victoria,undefined
[6] 3065,undefined
[7] Australia,undefined
[8] University of Melbourne Department of Medicine,undefined
[9] St. Vincent's Hospital,undefined
[10] Fitzroy,undefined
[11] Australia,undefined
[12] Monash University Department of Medicine,undefined
[13] Alfred Hospital,undefined
[14] Prahran,undefined
[15] Australia,undefined
[16] The Haartman Institute,undefined
[17] Division of Bacteriology and Immunology,undefined
[18] University of Helsinki,undefined
[19] Finland,undefined
[20] Centre Hospitalier Universitaire de Grenoble,undefined
[21] France,undefined
来源：
Diabetologia | 2002年 / 45卷
关键词：
Nephrin podocyte proteinuria diabetic nephropathy angiotensin converting enzyme inhibition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Abstract
引用
收藏
页码：1572 / 1576
页数：4
相关论文
共 50 条
  • [31] EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON THE PROGRESSION OF DIABETIC NEPHROPATHY
    RUILOPE, LM
    JOURNAL OF HYPERTENSION, 1995, 13 : S91 - S93
  • [32] Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice
    Nadarajah, Renisha
    Milagres, Rosangela
    Dilauro, Marc
    Gutsol, Alex
    Xiao, Fengxia
    Zimpelmann, Joseph
    Kennedy, Chris
    Wysocki, Jan
    Batlle, Daniel
    Burns, Kevin D.
    KIDNEY INTERNATIONAL, 2012, 82 (03) : 292 - 303
  • [33] A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy
    Pathak, Jahnavi V.
    Dass, Ervilla E.
    INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (02) : 148 - 152
  • [34] Deleterious effect of a deletion polymorphism in angiotensin-converting enzyme gene on progress on of diabetic nephropathy during angiotensin-converting enzyme inhibition
    Jacobsen, P
    Tarnow, L
    Rossing, P
    Cambien, F
    Lecerf, L
    Poirier, O
    Parving, HH
    DIABETOLOGIA, 1996, 39 : 1133 - 1133
  • [35] BENEFICIAL-EFFECTS OF ANGIOTENSIN CONVERTING ENZYME-INHIBITION ON RENAL-FUNCTION IN PATIENTS WITH DIABETIC NEPHROPATHY
    BJORCK, S
    NYBERG, G
    MULEC, H
    GRANERUS, G
    HERLITZ, H
    AURELL, M
    BMJ-BRITISH MEDICAL JOURNAL, 1986, 293 (6545): : 471 - 474
  • [36] BENEFICIAL-EFFECTS OF ANGIOTENSIN CONVERTING ENZYME-INHIBITION ON RENAL-FUNCTION IN PATIENTS WITH DIABETIC NEPHROPATHY
    AHMAD, S
    BRITISH MEDICAL JOURNAL, 1986, 293 (6553): : 1028 - 1028
  • [37] Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Wang, Gang
    Lai, Fernand Mac-Moune
    Lai, Ka-Bik
    Chow, Kai-Ming
    Kwan, Bonnie Ching-Ha
    Li, Philip Kam-Tao
    Szeto, Cheuk-Chun
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (03) : 317 - 322
  • [38] Angiotensin converting enzyme inhibition does not attenuate CTGF over-expression in human or rodent diabetic nephropathy.
    Langham, RG
    Kelly, DJ
    Cox, AJ
    Zaoui, P
    Pinel, N
    Cordonnier, D
    Gilbert, RE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 131A - 131A
  • [39] Angiotensin Converting Enzyme (Ace) Inhibitors in the Treatment of Diabetic Nephropathy
    Kumari, Sunita
    Kumar, S. L. Hari
    Navis, Silvia
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2015, 4 (04): : 211 - 217
  • [40] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN DIABETIC NEPHROPATHY
    MELCHIOR, WR
    BINDLISH, V
    JABER, LA
    ANNALS OF PHARMACOTHERAPY, 1993, 27 (03) : 344 - 350
12345